Overview
Drug allergy refers to an immune-mediated adverse reaction in which the body incorrectly recognizes a medication as a harmful agent. In susceptible individuals, IgE antibodies are formed against the drug or its metabolites, initiating an allergic cascade.
Following re-exposure, mast cells and basophils become activated and release inflammatory mediators such as histamine and cytokines, producing a wide range of systemic effects. These responses are classified under hypersensitivity reactions, affecting the skin, airways, gastrointestinal tract, or cardiovascular system depending on severity.
Clinical presentation may appear within minutes to hours in immediate reactions or after several days in delayed responses. Severe cases may progress to anaphylaxis, a life-threatening condition requiring urgent intervention.
Accurate identification through drug allergy testing is essential to confirm the offending agent, avoid re-exposure, and ensure safe selection of alternative therapies.
Symptoms
Clinical features vary widely depending on immune response type. Early manifestations may include skin eruptions, itching, and urticaria, along with facial or lip swelling and fever.
Respiratory involvement may present with wheezing, chest tightness, rhinorrhea, and breathlessness. In severe immediate reactions, progression to anaphylaxis may occur, leading to hypotension, dizziness, and collapse.
Delayed manifestations can include serum sickness, characterized by fever, joint pain, rash, and systemic discomfort. A more severe delayed immune response is drug reaction with eosinophilia and systemic symptoms, which may involve high fever, lymph node enlargement, and multi-organ dysfunction.
Life-threatening cutaneous reactions such as Stevens–Johnson syndrome and toxic epidermal necrolysis cause extensive blistering, mucosal damage, and systemic complications requiring emergency care.
Causes
Abnormal immune recognition of medications triggers multiple immunological pathways. IgE-mediated mechanisms involve immediate hypersensitivity, while immune complex reactions and cytotoxic pathways lead to hematologic injury and vascular inflammation.
T-cell mediated responses contribute to delayed hypersensitivity reactions affecting the skin and internal organs.
Certain drug classes are commonly associated with these reactions, including antibiotics, antiepileptics, and nonsteroidal anti-inflammatory drugs (NSAIDs), along with some cardiovascular and psychiatric medications. Non-immune reactions may mimic allergic responses but do not involve true immune activation.
Risk Factors
Previous exposure to the same or structurally similar medication increases sensitization risk. Individuals with a history of atopy, asthma, or familial allergic tendency are more prone to reactions.
Genetic variations influencing drug metabolism and immune regulation contribute significantly. Repeated exposure, polypharmacy, chronic illnesses, female sex, and older age further increase susceptibility.
Concurrent viral infections and immune dysregulation can amplify the likelihood of adverse immune responses.
Prevention
Effective management focuses on strict avoidance of the identified trigger medication and clear documentation of allergy history across all healthcare interactions.
Patients are advised to carry medical identification detailing known allergies to prevent accidental exposure. Confirmatory evaluation using drug allergy testing helps distinguish true reactions from non-allergic adverse effects.
When necessary, supervised desensitization may be performed to enable essential treatment when no alternatives exist. Education, early recognition of symptoms, and emergency preparedness remain central to reducing recurrence and severity of reactions.
